Scott Gottlieb (L) and Comanche Biopharma CEO Scott Johnson
January 17, 2024 06:00 AM EST
Financing
Startups

Co­manche se­cures $75M to test preeclamp­sia siR­NA in PhII, adds Scott Got­tlieb to board

Kyle LaHucik

Senior Reporter

Co­manche Bio­phar­ma, an siR­NA biotech cre­at­ed by vet­er­ans of The Med­i­cines Com­pa­ny, has reeled in a $75 mil­lion Se­ries B to test its drug can­di­date …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Ma­jor PBM re­forms fea­ture in Con­gress' year-end spend­ing bill

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

A service from the Financial Times